156264-79-8 Usage
Benzene derivative
A chemical compound derived from benzene a six-carbon ring structure with delocalized electrons.
Bromine atom at position 1
A bromine atom (Br) is attached to the first carbon atom of the benzene ring.
tert-Butyl group at position 3
A tert-butyl group (C4H9) is attached to the third carbon atom of the benzene ring.
Nitro group at position 5
A nitro group (-NO2) is attached to the fifth carbon atom of the benzene ring.
Organic synthesis
Commonly used in organic synthesis, which involves the chemical reactions and formation of carbon-containing compounds.
Starting material
Serves as a starting material for the preparation of various pharmaceutical and agrochemical products.
Building block
Used as a building block in the production of dyes, pigments, and other fine chemicals.
Potentially hazardous chemical
1-bromo-3-tert-butyl-5-nitrobenzene is a potentially hazardous chemical due to its reactivity and potential health risks.
Safety precautions
Should be handled and stored with appropriate safety measures, such as wearing protective gear and using proper storage containers.
Check Digit Verification of cas no
The CAS Registry Mumber 156264-79-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,6,2,6 and 4 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 156264-79:
(8*1)+(7*5)+(6*6)+(5*2)+(4*6)+(3*4)+(2*7)+(1*9)=148
148 % 10 = 8
So 156264-79-8 is a valid CAS Registry Number.
156264-79-8Relevant academic research and scientific papers
URACIL OR THYMINE DERIVATIVE FOR TREATING HEPATITIS C
-
Page/Page column 196, (2009/04/25)
Present application relates to the compounds of formula I useful to treat hepatitis C (HCV) infections. In the structure of the disclosed compounds is the uracil or thymine derivative linked via a phenylene into either fused 2-ring cyclic system (R6) or alternatively via additional two-atom linker (L) to a 5-6 membered monocycle (R6). Application further discloses polymorphs and pseudopolymorphs of two specific compounds: N-(6(3-t-butyl-5-(2>4-dioxo-3,4-dihydropyrimidin-1 (2H)- y!)2-methoxy-phenyl)naphthalen-2-yl)methanesulfonamide and (E)-N-(4(3-t- butyl-5-(2,4-dioxo-3)4-dihydropyrimidin-1 (2H)-yl)2-methoxy-styryl- phenyl)methanesulfonamide.
ANTI-INFECTIVE PYRIMIDINES AND USES THEREOF
-
Page/Page column 125, (2009/04/25)
This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.
